Holger Reithinger, PhD, Senior Advisor at Forbion, will join a panel discussion at ZEIT für Forschung zu Gast bei der Bayer AG in Berlin on 1 October 2026.
Hosted by DIE ZEIT and Bayer AG, the event will bring together leaders from science, business and politics to discuss the future of medicine. The programme will explore how artificial intelligence, emerging technologies and personalised therapies can translate scientific research into meaningful progress, as well as the conditions needed for Europe to remain a competitive centre for healthcare innovation.
The event begins at 17:30 at Bayer AG’s Pharmaceuticals Division.